Selected research
Market Structure
Global Nitroglycerin for Angina Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Nitroglycerin for Angina market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Nitroglycerin for Angina is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Nitroglycerin for Angina is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Nitroglycerin for Angina is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Nitroglycerin for Angina is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Nitroglycerin for Angina include Sandoz, Mylan, Pfizer, Us Pharma, Sigmapharm Laboratories, Hercon Pharmaceuticals, Glenmark, Espero Pharmaceuticals and Dr. Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Nitroglycerin for Angina market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Nitroglycerin for Angina and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Nitroglycerin for Angina sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nitroglycerin for Angina market size, projected growth trends, production technologies, key applications, and end-use industries.
Nitroglycerin for Angina Segment by Company
Sandoz
Mylan
Pfizer
Us Pharma
Sigmapharm Laboratories
Hercon Pharmaceuticals
Glenmark
Espero Pharmaceuticals
Dr. Reddy's Laboratories
Nitroglycerin for Angina Segment by Type
Transdermal
Tablet
Powder
Nitroglycerin for Angina Segment by Application
Relief
Prophylaxis
Nitroglycerin for Angina Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nitroglycerin for Angina market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nitroglycerin for Angina and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nitroglycerin for Angina.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Nitroglycerin for Angina market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nitroglycerin for Angina manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nitroglycerin for Angina in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Nitroglycerin for Angina in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Transdermal
- Tablet
- Powder
Applications
- Relief
- Prophylaxis
Companies covered
- Sandoz
- Mylan
- Pfizer
- Us Pharma
- Sigmapharm Laboratories
- Hercon Pharmaceuticals
- Glenmark
- Espero Pharmaceuticals
- Dr. Reddy's Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Nitroglycerin for Angina Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Nitroglycerin for Angina Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Nitroglycerin for Angina Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Nitroglycerin for Angina Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Nitroglycerin for Angina Market Dynamics
- 2.1 Nitroglycerin for Angina Industry Trends
- 2.2 Nitroglycerin for Angina Industry Drivers
- 2.3 Nitroglycerin for Angina Industry Opportunities and Challenges
- 2.4 Nitroglycerin for Angina Industry Restraints
3 Nitroglycerin for Angina Market by Manufacturers
- 3.1 Global Nitroglycerin for Angina Revenue by Manufacturers (2021-2026)
- 3.2 Global Nitroglycerin for Angina Sales by Manufacturers (2021-2026)
- 3.3 Global Nitroglycerin for Angina Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Nitroglycerin for Angina Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Nitroglycerin for Angina Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Nitroglycerin for Angina Manufacturers, Product Type & Application
- 3.7 Global Nitroglycerin for Angina Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Nitroglycerin for Angina Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Nitroglycerin for Angina Players Market Share by Revenue in 2025
- 3.8.3 2025 Nitroglycerin for Angina Tier 1, Tier 2, and Tier 3
4 Nitroglycerin for Angina Market by Type
- 4.1 Nitroglycerin for Angina Type Introduction
- 4.1.1 Transdermal
- 4.1.2 Tablet
- 4.1.3 Powder
- 4.2 Global Nitroglycerin for Angina Sales by Type
- 4.2.1 Global Nitroglycerin for Angina Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Nitroglycerin for Angina Sales by Type (2021-2032)
- 4.2.3 Global Nitroglycerin for Angina Sales Market Share by Type (2021-2032)
- 4.3 Global Nitroglycerin for Angina Revenue by Type
- 4.3.1 Global Nitroglycerin for Angina Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Nitroglycerin for Angina Revenue by Type (2021-2032)
- 4.3.3 Global Nitroglycerin for Angina Revenue Market Share by Type (2021-2032)
5 Nitroglycerin for Angina Market by Application
- 5.1 Nitroglycerin for Angina Application Introduction
- 5.1.1 Relief
- 5.1.2 Prophylaxis
- 5.2 Global Nitroglycerin for Angina Sales by Application
- 5.2.1 Global Nitroglycerin for Angina Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Nitroglycerin for Angina Sales by Application (2021-2032)
- 5.2.3 Global Nitroglycerin for Angina Sales Market Share by Application (2021-2032)
- 5.3 Global Nitroglycerin for Angina Revenue by Application
- 5.3.1 Global Nitroglycerin for Angina Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Nitroglycerin for Angina Revenue by Application (2021-2032)
- 5.3.3 Global Nitroglycerin for Angina Revenue Market Share by Application (2021-2032)
6 Global Nitroglycerin for Angina Sales by Region
- 6.1 Global Nitroglycerin for Angina Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Nitroglycerin for Angina Sales by Region (2021-2032)
- 6.2.1 Global Nitroglycerin for Angina Sales by Region (2021-2026)
- 6.2.2 Global Nitroglycerin for Angina Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Nitroglycerin for Angina Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Nitroglycerin for Angina Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Nitroglycerin for Angina Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Nitroglycerin for Angina Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Nitroglycerin for Angina Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Nitroglycerin for Angina Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Nitroglycerin for Angina Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Nitroglycerin for Angina Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Nitroglycerin for Angina Revenue by Region
- 7.1 Global Nitroglycerin for Angina Revenue by Region
- 7.1.1 Global Nitroglycerin for Angina Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Nitroglycerin for Angina Revenue by Region (2021-2026)
- 7.1.3 Global Nitroglycerin for Angina Revenue by Region (2027-2032)
- 7.1.4 Global Nitroglycerin for Angina Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Nitroglycerin for Angina Revenue (2021-2032)
- 7.2.2 North America Nitroglycerin for Angina Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Nitroglycerin for Angina Revenue (2021-2032)
- 7.3.2 Europe Nitroglycerin for Angina Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Nitroglycerin for Angina Revenue (2021-2032)
- 7.4.2 Asia-Pacific Nitroglycerin for Angina Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Nitroglycerin for Angina Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Nitroglycerin for Angina Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sandoz
- 8.1.1 Sandoz Company Information
- 8.1.2 Sandoz Business Overview
- 8.1.3 Sandoz Nitroglycerin for Angina Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sandoz Nitroglycerin for Angina Product Portfolio
- 8.1.5 Sandoz Recent Developments
- 8.2 Mylan
- 8.2.1 Mylan Company Information
- 8.2.2 Mylan Business Overview
- 8.2.3 Mylan Nitroglycerin for Angina Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Mylan Nitroglycerin for Angina Product Portfolio
- 8.2.5 Mylan Recent Developments
- 8.3 Pfizer
- 8.3.1 Pfizer Company Information
- 8.3.2 Pfizer Business Overview
- 8.3.3 Pfizer Nitroglycerin for Angina Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Pfizer Nitroglycerin for Angina Product Portfolio
- 8.3.5 Pfizer Recent Developments
- 8.4 Us Pharma
- 8.4.1 Us Pharma Company Information
- 8.4.2 Us Pharma Business Overview
- 8.4.3 Us Pharma Nitroglycerin for Angina Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Us Pharma Nitroglycerin for Angina Product Portfolio
- 8.4.5 Us Pharma Recent Developments
- 8.5 Sigmapharm Laboratories
- 8.5.1 Sigmapharm Laboratories Company Information
- 8.5.2 Sigmapharm Laboratories Business Overview
- 8.5.3 Sigmapharm Laboratories Nitroglycerin for Angina Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Sigmapharm Laboratories Nitroglycerin for Angina Product Portfolio
- 8.5.5 Sigmapharm Laboratories Recent Developments
- 8.6 Hercon Pharmaceuticals
- 8.6.1 Hercon Pharmaceuticals Company Information
- 8.6.2 Hercon Pharmaceuticals Business Overview
- 8.6.3 Hercon Pharmaceuticals Nitroglycerin for Angina Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Hercon Pharmaceuticals Nitroglycerin for Angina Product Portfolio
- 8.6.5 Hercon Pharmaceuticals Recent Developments
- 8.7 Glenmark
- 8.7.1 Glenmark Company Information
- 8.7.2 Glenmark Business Overview
- 8.7.3 Glenmark Nitroglycerin for Angina Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Glenmark Nitroglycerin for Angina Product Portfolio
- 8.7.5 Glenmark Recent Developments
- 8.8 Espero Pharmaceuticals
- 8.8.1 Espero Pharmaceuticals Company Information
- 8.8.2 Espero Pharmaceuticals Business Overview
- 8.8.3 Espero Pharmaceuticals Nitroglycerin for Angina Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Espero Pharmaceuticals Nitroglycerin for Angina Product Portfolio
- 8.8.5 Espero Pharmaceuticals Recent Developments
- 8.9 Dr. Reddy's Laboratories
- 8.9.1 Dr. Reddy's Laboratories Company Information
- 8.9.2 Dr. Reddy's Laboratories Business Overview
- 8.9.3 Dr. Reddy's Laboratories Nitroglycerin for Angina Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Dr. Reddy's Laboratories Nitroglycerin for Angina Product Portfolio
- 8.9.5 Dr. Reddy's Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Nitroglycerin for Angina Value Chain Analysis
- 9.1.1 Nitroglycerin for Angina Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Nitroglycerin for Angina Production Mode & Process
- 9.2 Nitroglycerin for Angina Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Nitroglycerin for Angina Distributors
- 9.2.3 Nitroglycerin for Angina Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst